Longeveron Inc.
Ticker(s):
LGVN
Country:
Sector & Industry:
Business Overview
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company’s lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer’s disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Contact & Other Information
Number of Employees:
23
Website:
,
,
Longeveron Inc. announced the resignation of Marcum LLP as their independent registered public accounting firm and the engagement of CBIZ CPAs P.C. as their new auditor.